Clinical Trials Browser

Phase 1/2 × INDUSTRY × Radiodermatitis × Clear all

NCT04261387 2022-07-27

LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients

Phase 1/2 Completed

Breast Neoplasms, Dermatitis, Radiodermatitis

NCT02534129 2017-10-06

Topical Use of Difinsa53™ to Prevent Radiation Dermatitis

Phase 1/2 Terminated

13 enrolled 3 charts

Breast Neoplasms, Dermatitis, Radiodermatitis

NCT01544504 2012-05-28

Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy

Phase 1/2 Withdrawn

Radiodermatitis